| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/09/2003 | US20030007946 Applying polymerizable monomer and fungicide; applying to skins |
| 01/09/2003 | US20030007944 Spraying skins; mixture containing polyurethane binder |
| 01/09/2003 | US20030007941 Method of treating hair loss using thyromimetic compounds |
| 01/09/2003 | US20030007936 Chewing gum to control malodorous breath |
| 01/09/2003 | US20030007934 Delivery of stimulants through an inhalation route |
| 01/09/2003 | US20030007933 Delivery of muscle relaxants through an inhalation route |
| 01/09/2003 | US20030007932 Drug delivery; overcoated solid dried active solid |
| 01/09/2003 | US20030007930 Novel methods and compositions for delivering macromolecules to or via the respiratory tract |
| 01/09/2003 | US20030007929 Topical steroid spray |
| 01/09/2003 | US20030007826 Applying polymerizable monomer adhesive composition, optionally a fungicide, allowing to polymerize to form film |
| 01/09/2003 | US20030006326 Device for pulverizing desiccated bulk product in a freeze-drying apparatus for foodstuffs, medicaments, and so forth |
| 01/09/2003 | US20030005927 Process and device for inhalation of particulate medicaments |
| 01/09/2003 | US20030005925 Delivery of rizatriptan or zolmitriptan through an inhalation route |
| 01/09/2003 | US20030005924 Delivery of beta-blockers through an inhalation route |
| 01/09/2003 | CA2452393A1 Hydrophobic dopamine agonists administered to the dermis |
| 01/09/2003 | CA2452364A1 Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins |
| 01/09/2003 | CA2452321A1 Enhanced pharmacokinetic profile of hydrophobic substances |
| 01/09/2003 | CA2452200A1 Method for identifying compounds that specifically deplete mast cells |
| 01/09/2003 | CA2452030A1 Sustained release pharmaceutical composition |
| 01/09/2003 | CA2451975A1 Tolterodine metabolites |
| 01/09/2003 | CA2451846A1 Cancer vaccine comprizing a cancer antigen based on the product of a tumor suppressor gene wt1 and a cationic liposome |
| 01/09/2003 | CA2451739A1 Hcv e1e2 vaccine compositions |
| 01/09/2003 | CA2451580A1 Artificial synapse chip interface for electronic prosthetic retina |
| 01/09/2003 | CA2451195A1 Antitumoral formulations of thioxanthenone |
| 01/09/2003 | CA2450361A1 Dry powder electrostatic deposition method and apparatus |
| 01/09/2003 | CA2450354A1 Enhanced systemic absorption of intradermally delivered substances |
| 01/08/2003 | EP1273861A1 Device for pulverizing desiccated bulk product in a freeze-drying apparatus for foodstuffs, medicaments, and so forth |
| 01/08/2003 | EP1273307A1 Preparations for preventing bile acid diarrhea |
| 01/08/2003 | EP1273306A1 Powdery preparation for transmucosal administration containing a polymeric form of drug and exhibiting improved storage stability |
| 01/08/2003 | EP1273305A1 Medical preparation for inhalation comprising Antithrombin for treating inflammatory lung diseases and ARDS |
| 01/08/2003 | EP1273301A2 Pharmaceutical preparations based on active ingredients susceptible to illicit administration |
| 01/08/2003 | EP1273300A2 A stable external preparation containing aspirin |
| 01/08/2003 | EP1273296A2 Combination chemotherapy |
| 01/08/2003 | EP1273294A1 Fenofibrate pharmaceutical composition with a higher bioavailability and its manufacturing process |
| 01/08/2003 | EP1273293A1 Fenofibrate suspension in a hydrophilic polymer solution |
| 01/08/2003 | EP1273292A1 Optimised formulation of tobramycin for aerosolization |
| 01/08/2003 | EP1273291A1 Brittle-coating, soft core dosage form |
| 01/08/2003 | EP1273290A1 Large porous particles emitted from an inhaler |
| 01/08/2003 | EP1273289A1 Pharmaceutical compositions containing ascomycin derivatives |
| 01/08/2003 | EP1273288A1 Pharmaceutical compositions containing rapamycin derivatives |
| 01/08/2003 | EP1273287A1 Oily compositions containing highly fat-soluble drugs |
| 01/08/2003 | EP1272907A2 Compliance tracking method |
| 01/08/2003 | EP1272561A1 Pressure sensitive adhesive compositions |
| 01/08/2003 | EP1272470A1 Amorphous torasemide modification |
| 01/08/2003 | EP1272236A1 Methods and compositions for treating intervertebral disc degeneration |
| 01/08/2003 | EP1272225A2 Lipid-based systems for targeting diagnostic agents |
| 01/08/2003 | EP1272220A1 Formulation for the prevention of cardiovascular disease |
| 01/08/2003 | EP1272197A2 Combination of lecithin with ascorbic acid |
| 01/08/2003 | EP1272196A2 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha,11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 01/08/2003 | EP1272184A2 Pharmaceutical compositions comprising salmeterol and ipratropium |
| 01/08/2003 | EP1272183A1 Methods and compositions useful in enhancing oxygen delivery to cells |
| 01/08/2003 | EP1272181A2 Modified release formulations containing a hypnotic agent |
| 01/08/2003 | EP1272180A1 Concentrated solutions of carvedilol |
| 01/08/2003 | EP1272179A1 Hydrophilic molecular disperse solutions of carvedilol |
| 01/08/2003 | EP1272177A1 Method and formulation for treating resistance to antihypertensives and related conditions |
| 01/08/2003 | EP1272176A1 Adamantyl derivatives as anti-cancer agents |
| 01/08/2003 | EP1272167A1 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 01/08/2003 | EP1272166A2 Pharmaceutical compositions comprising fluvastatin |
| 01/08/2003 | EP1272165A1 Acrylic enteric coating compositions |
| 01/08/2003 | EP1272164A1 Method for stabilising particle size distribution of a powdery active principle dispersed in a liquid and uses thereof |
| 01/08/2003 | EP1272163A2 Pharmaceutical compositions |
| 01/08/2003 | EP1272162A1 Stabilized dry powder formulations |
| 01/08/2003 | EP1272161A2 Lipid-based drug delivery systems against parasitic infections |
| 01/08/2003 | EP1272160A2 Lipid-based drug delivery systems for topical application |
| 01/08/2003 | EP1272157A2 Topical micronutrient delivery system and uses thereof |
| 01/08/2003 | EP1272155A1 Use of natural substances in the production of cosmetic preparations |
| 01/08/2003 | EP1272059A2 Method of producing oily suspensions of water-soluble vitamins |
| 01/08/2003 | EP1272044A1 Protein stabilised emulsions |
| 01/08/2003 | EP1124594B1 Implant with cavities containing therapeutic agents |
| 01/08/2003 | EP1098651B1 Novel urokinase inhibitors |
| 01/08/2003 | EP1021192B1 Dexamethasone gel |
| 01/08/2003 | EP0981375B1 Pharmaceutical compositions containing plasma protein |
| 01/08/2003 | EP0980215B1 Encapsulated material with controlled release |
| 01/08/2003 | EP0934041A4 Hydrogel wound dressing and the method of making and using the same |
| 01/08/2003 | EP0906107B1 Compositions comprising vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs |
| 01/08/2003 | EP0859622B1 Extracts of shark cartilage |
| 01/08/2003 | EP0664307B1 Base polymer for percutaneously absorbable preparation |
| 01/08/2003 | EP0646012B1 WOUND HEALING AND TREATMENT OF FIBROTIC DISORDERS BY TGFbeta-3 |
| 01/08/2003 | CN1390228A Orally active A adenosine receptor agonists |
| 01/08/2003 | CN1390153A Method of the production of particles |
| 01/08/2003 | CN1390143A Amphiphilic prodrugs |
| 01/08/2003 | CN1390142A Taxane prodrugs |
| 01/08/2003 | CN1390135A Topical treatment of streptococcal infections |
| 01/08/2003 | CN1390134A The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 01/08/2003 | CN1390129A Solutions containing epinastine |
| 01/08/2003 | CN1390127A Antifungal oral composition containing itraconazole and process for preparing same |
| 01/08/2003 | CN1390121A Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 01/08/2003 | CN1390120A Compression molded product and production method therefor |
| 01/08/2003 | CN1390119A Process for making aqueous coated beadlets |
| 01/08/2003 | CN1390118A Dextrose and insulin fluid formulation for intravenous infusion |
| 01/08/2003 | CN1389470A Stabilizer for recombinant alpha-interferon liquid |
| 01/08/2003 | CN1389259A Psoriasis-treating ointment and its compounding process |
| 01/08/2003 | CN1389240A Gingko leaf powder for injection and its prepn. |
| 01/08/2003 | CN1389219A Prepn. of nano alcohol-soluble particle Chinese medicine |
| 01/08/2003 | CN1389211A Puerarin injection and its prepn. process |
| 01/08/2003 | CN1389208A Orally taken pulsed releasing system of phenyl diazepine medicine and its prepn. |
| 01/08/2003 | CN1389205A Soft bilobalide capsule and its prepn. |
| 01/08/2003 | CN1389203A Method for treating hair-dropping using thyromimetic compound |
| 01/08/2003 | CN1389202A Levo-salbutamol hydrochloride aerosol and its prepn. |
| 01/08/2003 | CN1389200A Dexamethasone acetate plaster and its prepn. |